The Advertising Research Foundation Unveils Findings From Attention Measurement Validation Initiative Phase Two Report
May 16, 2024 12:20 ET | Advertising Research Foundation
ARF released findings comparing 12 attention measurement companies at ATTENTION 2024 in New York.
Visory Health Logo.png
Visory Health's New Prescription Habits Report Reveals Medication Affordability Challenges Among Millennials, the Sandwich Generation and Beyond
May 07, 2024 09:00 ET | Visory Health
ESTERO, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Visory Health, a women-led, patient-first health tech prescription platform that is transforming the way women, families, and caregivers access...
111Boehringer_Ingelheim_Logo_RGB_Dark_Green (002).png
Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia
May 06, 2024 05:00 ET | Boehringer Ingelheim
Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic...
Volvo Spread Word Mark – Black-01.png
Volvo Study Reveals, 64% of Canadians Are Eyeing Electrified Vehicles for Next Purchase
May 01, 2024 10:00 ET | Volvo Car Canada Ltd.
RICHMOND HILL, Ontario, May 01, 2024 (GLOBE NEWSWIRE) -- Despite industry headwinds, 64% of Canadians looking to purchase a new vehicle say they would consider a hybrid, plug-in hybrid, or fully...
AmeriCorps member
AmeriCorps Releases Report on Volunteer Generation Fund Evaluation and Capacity Building Project
April 25, 2024 14:21 ET | AmeriCorps
Washington, DC, April 25, 2024 (GLOBE NEWSWIRE) -- AmeriCorps, the federal agency for national service and volunteering, released the AmeriCorps Volunteer Generation Fund Bundle Evaluation and...
Ongoing Point of Care Ultrasound Certification Academy Study Aims to Identify Top 25 POCUS Practice Domains
April 10, 2024 11:57 ET | Inteleos, Inc.
ROCKVILLE, Md., April 10, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, through its Point-of-Care Ultrasound (POCUS) Certification Academy (PCA),...
Logo Officiel Smaller.png
Glimpact Releases Top Environmental Tips for Super Bowl Watch Parties
February 09, 2024 19:20 ET | Glimpact
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Glimpact, a global platform to evaluate products’ and organizations’ environmental footprint, shares the findings of its study on popular Super Bowl...
LIXTE Biotechnology Announces a Supported Collaborative Trial to Study LIXTE’s First-in-Class PP2A Inhibitor, LB-100, Plus GSK’s Immunotherapy, Dostarlimab, in Clear-Cell Ovarian Cancer
September 20, 2023 08:30 ET | Lixte Biotechnology Holdings, Inc.
The Phase 1b Clinical Trial Focuses on Assessing the Safety and Efficacy of the Two-Drug Combination in a Cancer Associated with Longer Survival to Immunotherapy When Genetically Deficient in PP2A ...
Study Validating MoA of Intranasal Foralumab in Alzheimer’s Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance
September 06, 2023 07:00 ET | Tiziana Life Sciences Ltd.
The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”FDA has cleared the IND for intranasal...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, TRUSTED INVESTOR COUNSEL, FIRM Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
August 19, 2023 17:52 ET | The Rosen Law Firm PA
NEW YORK, Aug. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and...